F Fuzkk Atlas of the USA
#126Extended selection 101–500

Cellares

California

API / CDMO / manufacturingCell and gene therapy

Manufacturing profile

API / CDMO / manufacturing
Cell and gene therapy

Biopharma hub: California

Selection basis

The company is placed in positions 101–500 as a manufacturer, biotech, generics, advanced-therapy company or CDMO with practical relevance to the FUZKK utility catalog.

The Top 500 is a FUZKK atlas priority rather than a single official revenue table. Inclusion in an FDA or industry source does not mean product approval, confirmation of a site's current status or actual use of FUZKK.

Representative manufacturing and QC chain

  1. 1Route development, raw materials and scale-up
  2. 2Synthesis, bioprocessing or formulation development
  3. 3Purification, filtration, drying or aseptic processing
  4. 4Technology transfer, cleaning and change control
  5. 5HPLC/GC/KF/ICP/LC-MS and validation evidence
  6. 6Starting-material and cell-bank control
  7. 7Cell expansion or vector production
  8. 8Purification, concentration and formulation
  9. 9Identity, viability, potency and qPCR

Relevant FUZKK packages

United States: national essential medicines QC packageGlobal API & Biosimilars QC SuiteWorld API Extension QC SuiteFermentation & Antibiotic Intermediates QC SuiteLumex QC SuiteCell & Gene Therapy / Viral Vector QC Suite

Product/API utilities

Vector Genome Titer q PCR AnalyzerReplication Competent Virus RCV Quality CheckerResidual Host Cell DNA Quality CheckerResidual Host Protein Checker

Lumex — instrumental QC

Method Validation Data Packager

LabEx — laboratory QC

Assay & Impurity HPLC Quality CheckerResidual Solvents GC Quality CheckerWater Content KF Quality CheckerElemental Impurities ICP Quality CheckerLC-MS Confirmation Quality CheckerSterility Test Membrane Filtration Quality CheckerBacterial Endotoxins LAL Quality Checker

Medical Devices — equipment and software lifecycle

Process Validation CheckerChange Control Impact CheckerSupplier Evaluation CheckerProduction Record Consistency CheckerCalibration Status CheckerRequirement Traceability CheckerData Integrity Security Checker

Suggested first pilot

  1. Confirm one real product, method or recurring QC review.
  2. Record the instrument, export format and current specification.
  3. Select 3–7 utilities from the map above.
  4. Run a PASS/FAIL sample and agree the expected output.
  5. After user validation, expand to other products and sites.

Mapping boundary

The Top 500 is a FUZKK atlas priority rather than a single official revenue table. Inclusion in an FDA or industry source does not mean product approval, confirmation of a site's current status or actual use of FUZKK.

Methodology